ACTIVE

Viatris

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

4,2 M €

-22.4% YoY

Revenue

163,7 M €

-14.7% YoY

Equity

96,5 M €

+4.6% YoY

Workforce

137,5 ETP

-1.4% YoY

What does Viatris do?

Viatris is a Private limited company incorporated in 2014. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Hoeilaart. It employs on average 137,5 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0564.907.115

Incorporation

21/10/2014

Legal form

Private limited company

Registered office

Terhulpsesteenweg 6 box A
1560 Hoeilaart · FlandreSee on map

Contributed capital

68 800 000,00 €

Latest accounts

31/12/2025

Average workforce

137,5 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 70200Management consultancy activities 70220Business and other management consultancy activities 82100Office administrative and support activities 82110Combined office administrative service activities

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 9 financial years

	2025		2024		2023		2022		2020		2019		2018		2017		2016
Income statement
Revenue	163,7 M €	-14.7%	191,9 M €	-18.5%	235,5 M €	+18.0%	199,6 M €	+338%	45,6 M €	+26.2%	36,1 M €	+27.5%	28,3 M €	+2.7%	27,6 M €	-8.3%	30,1 M €
EBITDA	7,1 M €	+18.4%	6 M €	-28.8%	8,4 M €	-15.4%	10 M €	+171%	3,7 M €	+191%	1,3 M €	-19.0%	1,6 M €	-35.6%	2,4 M €	+33.5%	1,8 M €
Operating result	8,9 M €	+9.7%	8,2 M €	-9.6%	9 M €	+37.1%	6,6 M €	+232%	2 M €	+110%	945 k €	+71.8%	550 k €	-55.0%	1,2 M €	+5.1%	1,2 M €
Net result	4,2 M €	-22.4%	5,4 M €	-11.1%	6,1 M €	+44.5%	4,2 M €	+199%	1,4 M €	+133%	608,8 k €	+70.5%	357 k €	-44.8%	647,2 k €	-22.6%	836,3 k €
Balance sheet
Equity	96,5 M €	+4.6%	92,3 M €	+6.3%	86,8 M €	+7.6%	80,7 M €	+10.4%	73,1 M €	+2.0%	71,7 M €	+0.9%	71,1 M €	+0.5%	70,8 M €	+0.9%	70,1 M €
Total assets	141,1 M €	-6.5%	150,9 M €	+2.1%	147,7 M €	-3.8%	153,6 M €	+77.2%	86,7 M €	+2.0%	84,9 M €	+6.8%	79,5 M €	-0.9%	80,2 M €	-1.7%	81,6 M €
Cash	56 €		–		–		684,9 k €	+26.8%	540 k €	+6.3%	507,9 k €	-68.1%	1,6 M €	+73.6%	917,4 k €	-52.6%	1,9 M €
Debts	44,6 M €	-23.9%	58,6 M €	-3.7%	60,9 M €	-16.4%	72,8 M €	+439%	13,5 M €	+2.3%	13,2 M €	+57.0%	8,4 M €	-10.7%	9,4 M €	-17.4%	11,4 M €
Other
Workforce	137,5 ETP	-1.4%	139,5 ETP	-8.2%	152,0 ETP	+5.4%	144,2 ETP	+356%	31,6 ETP	-3.4%	32,7 ETP	-9.7%	36,2 ETP	-8.1%	39,4 ETP	-19.6%	49,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 13 ended

Active mandates

Arun NARAYAN

Director · since 26 novembre 2025

Active

Tomasz BUCZEK

Director · since 25 juin 2025

Active

Ended mandates

Matthew Salzmann

Director · since 01 mars 2024

Ended

Luis BIRBUET

Director · since 03 février 2021

Ended

Vincent Verschraegen

Manager · since 18 décembre 2018

Ended

Vincent VERSCHRAEGEN

Director · since 18 décembre 2018

Ended

At this address

Other companies at this address

Company	CBE no.
DOCPHARMA● Active	0465.350.075
Matrix Laboratories● Liquidation	0874.864.378

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	07/07/2026	27/06/2025	27/06/2024	10/07/2023	10/10/2022	13/07/2021
General meeting	18/06/2026	19/06/2025	20/06/2024	28/06/2023	07/10/2022	17/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

13 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	18/06/2026	07/07/2026	Dutch	PDF
Full model	31/12/2024	19/06/2025	27/06/2025	Dutch	PDF
Full model	31/12/2023	20/06/2024	27/06/2024	Dutch	PDF
Full model	31/12/2022	28/06/2023	10/07/2023	Dutch	PDF
Full model	31/12/2021	07/10/2022	10/10/2022	Dutch	PDF
Full model	31/12/2020	17/06/2021	13/07/2021	Dutch	PDF
Full model	31/12/2019	18/06/2020	09/07/2020	Dutch	PDF
Full model	31/12/2018	20/06/2019	09/07/2019	Dutch	PDF
Full model	31/12/2017	31/08/2018	06/09/2018	Dutch	PDF
Consolidated accounts	31/12/2017	29/06/2018	07/11/2018	Dutch	PDF
Full model	31/12/2016	28/06/2017	06/07/2017	French	PDF
Consolidated accounts	31/12/2016	28/06/2017	02/08/2018	Dutch	PDF
Full model	31/12/2015	21/09/2016	27/09/2016	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 13 ended

Active mandates

Arun NARAYAN

Director · since 26 novembre 2025

Active

Tomasz BUCZEK

Director · since 25 juin 2025

Active

Ended mandates

Matthew Salzmann

Director · since 01 mars 2024

Ended

Luis BIRBUET

Director · since 03 février 2021

Ended

Vincent Verschraegen

Manager · since 18 décembre 2018

Ended

Vincent VERSCHRAEGEN

Director · since 18 décembre 2018

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Other02/07/2026
—
PDF
Mandates10/12/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates25/07/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/07/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates04/07/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates21/03/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/07/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates20/06/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 20254,2 M €↓
26/11/2025
nominationArun Narayan — bestuurder
03/07/2025
nominationTomasz Buczek — Country Manager / bijzondere volmacht
03/07/2025
nominationKristof Vanderhaegen — Head of Sales & Commercial Operations / bijzondere volmacht
03/07/2025
nominationCharlotte Loosveld — Tender Manager / bijzondere volmacht
03/07/2025
nominationMarie-Anne Van Malcot — Tender Associate / bijzondere volmacht
03/07/2025
nominationJohan Lagae — bijzondere volmacht
03/07/2025
nominationEls Bruis — bijzondere volmacht
25/06/2025
nominationTomasz Buczek — bestuurder
2024
Annual accounts 20245,4 M €↓
20/06/2024
reconductionDeloitte Bedrijfsrevisoren BV — commissaris
01/03/2024
nominationMatthew Salzmann — bestuurder
2023
Annual accounts 20236,1 M €↑
23/06/2023
nominationVincent Verschraegen — Country Manager / gemachtigde
23/06/2023
nominationKristof Vanderhaegen — Head of Sales & Commercial Operations / gemachtigde
23/06/2023
nominationCharlotte Loosveld — Tender Manager / gemachtigde
23/06/2023
nominationMarie-Anne Van Malcot — Tender Associate / gemachtigde
23/06/2023
nominationJohan Lagae — bijzondere volmacht
23/06/2023
nominationEls Bruls — bijzondere volmacht
2022
Annual accounts 20224,2 M €↑
2022
Name changeViatris BV
2020
Annual accounts 20201,4 M €↑
2019
Annual accounts 2019608,8 k €↑
2018
Annual accounts 2018357 k €↓
2017
Annual accounts 2017647,2 k €↓
2016
Annual accounts 2016836,3 k €
2016
Name changeMylan EPD
21/10/2014
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Viatris

Overview

What does Viatris do?

Trend over 9 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline